Davis, JW. Novel Commercially Available Genomic Tests for Prostate Cancer: A Roadmap to Understanding Their Clinical Impact. BJU Int. 2014; 114: 320–22.CrossRefGoogle ScholarPubMed

Dhawan, M, Ryan, CJ, Ashworth, A. DNA Repair Deficiency Is Common in Advanced Prostate Cancer: New Therapeutic Opportunities. Oncologist. 2016 Jun 17; pii: The Oncologist. 2016–0135. [Epub ahead of print].Google ScholarPubMed

Pritchard, CC, Mateo, J, Walsh, MF, De Sarkar, N, Abida, W, Beltran, H, Garofalo, A, Gulati, R, Carreira, S, Eeles, R, Elemento, O, Rubin, MA, Robinson, D, Lonigro, R, Hussain, M, Chinnaiyan, A, Vinson, J, Filipenko, J, Garraway, L, Taplin, ME, AlDubayan, S, Han, GC, Beightol, M, Morrissey, C, Nghiem, B, Cheng, HH, Montgomery, B, Walsh, T, Casadei, S, Berger, M, Zhang, L, Zehir, A, Vijai, J, Scher, HI, Sawyers, C, Schultz, N, Kantoff, PW, Solit, D, Robson, M, Van Allen, EM, Offit, K, de Bono, J, Nelson, PS. Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer. N Engl J Med. 2016 Jul 6. [Epub ahead of print].Google Scholar

Cheng, L, Davidson, DD, Maclennan, GT, Lopez-Beltran, A, Montironi, R, Wang, M, Tan, PH, Baldridge, LA, Zhang, S. Atypical Adenomatous Hyperplasia of Prostate Lacks TMPRSS2-ERG Gene Fusion. Am J Surg Pathol. 2013 Oct; 37(10): 1550–54. doi: 10.1097/PAS.0b013e318294e9bc.CrossRefGoogle ScholarPubMed

Castro, Elena, Eeles, Rosalind. The Role of BRCA1 and BRCA2 in Prostate Cancer. Asian Journal of Andrology. 2012; 14: 409–14.Google Scholar

Schelling, LA, Williamson, SR, Zhang, S, Yao, JL, Wang, M, Huang, J, Montironi, R, Lopez-Beltran, A, Emerson, RE, Idrees, MT, Osunkoya, AO, Man, YG, Maclennan, GT, Baldridge, LA, Compérat, E, Cheng, L. Frequent TMPRSS2-ERG Rearrangement in Prostatic Small Cell Carcinoma Detected by Fluorescence in Situ Hybridization: The Superiority of Fluorescence in Situ Hybridization over ERG Immunohistochemistry. Hum Pathol. 2013 Oct; 44(10): 2227–33. doi: 10.1016/j.humpath.2013.05.005. Epub 2013 Jul 12.Google Scholar

Rao, Q, Williamson, SR, Lopez-Beltran, A, Montironi, R, Huang, W, Eble, JN, Grignon, DJ, Koch, MO, Idrees, MT, Emerson, RE, Zhou, XJ, Zhang, S, Baldridge, LA, Cheng, L. Distinguishing Primary Adenocarcinoma of the Urinary Bladder from Secondary Involvement by Colorectal Adenocarcinoma: Extended Immunohistochemical Profiles Emphasizing Novel Markers. Mod Pathol. 2013 May; 26(5): 725–32. doi: 10.1038/modpathol.2012.229. Epub 2013 Jan.Google Scholar

Rubin, MA. ETS Rearrangements in Prostate Cancer. Asian Journal of Andrology. 2012; 14: 393–99.Google Scholar

Mazzucchelli, R, Scarpelli, M, Barbisan, F, Santinelli, A, Lopez-Beltran, A, Cheng, L, Montironi, R. Immunohistochemical Expression of Prostate Tumour Overexpressed 1 (PTOV1) in Atypical Adenomatous Hyperplasia (AAH) of the Prostate: Additional Evidence Linking (AAH) to Adenocarcinoma. Cell Oncol (Dordr). 2013 Feb; 36(1): 37–42. doi: 10.1007/s13402-012-0111-7.CrossRefGoogle Scholar

Quick, Charles M. MDa, Gokden, Neriman MDa, Sangoi, Ankur R. MDb, Brooks, James D. MDc, McKenney, Jesse K. MD. The Distribution of PAX-2 Immunoreactivity in the Prostate Gland, Seminal Vesicle, and Ejaculatory Duct: Comparison with Prostatic Adenocarcinoma and Discussion of Prostatic Zonal Embryogenesis. Human Pathology. 2010; 41: 1145–49.CrossRefGoogle ScholarPubMed

Harvey, Aaron M. MD, Grice, Beverly HTL, Hamilton, Candice HTL, Truong, Luan D. MD, Ro, Jae Y. MD, Ayala, Alberto G. MD, Zhai, Qihui ‘‘Jim’’ MD. Diagnostic Utility of P504S/p63 Cocktail Prostate-specific Antigen, and Prostatic Acid Phosphatase in Mazzucchelli, R, Barbisan, F, Santinelli, A, Lopez-Beltran, A, Cheng, L, Scarpelli, M, Montironi, R. Immunohistochemical Expression of Prostate Tumor Overexpressed 1 in Cystoprostatectomies with Incidental and Insignificant Prostate Cancer. Further Evidence for Field Effect in Prostatic Carcinogenesis. Hum Pathol. 2011 Dec; 42(12): 1931–36. Epub 2011 Jun 14.Google Scholar

Williamson, SR, Zhang, S, Yao, JL, Huang, J, Lopez-Beltran, A, Shen, S, Osunkoya, AO, MacLennan, GT, Montironi, R, Cheng, L. ERG-TMPRSS2 Rearrangement Is Shared by Concurrent Prostatic Adenocarcinoma and Prostatic Small Cell Carcinoma and Absent in Small Cell Carcinoma of the Urinary Bladder: Evidence Supporting Monoclonal Origin. Mod Pathol. 2011 Aug; 24(8): 1120–27. doi: 10.1038/modpathol.2011.56.CrossRefGoogle ScholarPubMed

Zhang, C, Montironi, R, MacLennan, GT, Lopez-Beltran, A, Li, Y, Tan, PH, Wang, M, Zhang, S, Iczkowski, KA, Cheng, L. Is Atypical Adenomatous Hyperplasia of the Prostate a Precursor Lesion? Prostate. 2011 Dec; 71(16): 1746–51. doi: 10.1002/pros.21391. Epub 2011 Apr 7.CrossRefGoogle ScholarPubMed

Wang, X, Jones, TD, Zhang, S, Eble, JN, Bostwick, DG, Qian, J, Lopez-Beltran, A, Montironi, R, Harris, JJ, Cheng, L. Amplifications of EGFR Gene and Protein Expression of EGFR, Her-2/Neu, c-kit, and Androgen Receptor in Phyllodes Tumor of the Prostate. Mod Pathol. 2007 Feb; 20(2): 175–82.Google Scholar

Hodges, KB, Abdul-Karim, FW, Wang, M, Lopez-Beltran, A, Montironi, R, Easley, S, Zhang, S, Wang, N, MacLennan, GT, Cheng, L. Evidence for Transformation of Fibroadenoma of the Breast to Malignant Phyllodes Tumor. Appl Immunohistochem Mol Morphol. 2009 Jul; 17(4): 345–50.Google Scholar

Smith, SC- Palanisamy, N, Zuhlke, KA, Johnson, AM, Siddiqui, J, Chinnaiyan, AM, Kunju, LP, Cooney, KA, Tomlins, SA. HOXB13 G84E-related Familial Prostate Cancers: A Clinical, Histologic, and Molecular Survey. Am J Surg Pathol. 2014 May; 38(5): 615–26.CrossRefGoogle ScholarPubMed

Fisher, KW, Zhang, S, Wang, M, Montironi, R, Wang, L, Baldrige, LA, Wang, JY, MacLennan, GT, Williamson, SR, Lopez-Beltran, A, Cheng, L. TMPRSS2-ERG Gene Fusion Is Rare Compared to PTEN Deletions in Stage T1a Prostate Cancer. Mol Carcinog. 2016 Aug 8; doi: 10.1002/mc.22535.CrossRefGoogle Scholar

Buti, S, Ciccarese, C, Iacovelli, R, Bersanelli, M, Scarpelli, M, Lopez-Beltran, A, Cheng, L, Montironi, R, Tortora, G, Massari, F. Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: Part 2 – Prostate and Bladder Cancer. Future Oncol. 2016 Sep; 12(17): 1971–74. doi: 10.2217/fon-2016–0166.Google Scholar

Monn, M. Francesca 1, Montironi, Rodolfo 2, Lopez-Beltran3,4 Antonio 3,4, Cheng1,5 Liang 1,5. Emerging Molecular Pathways and Targets in Neuroendocrine Prostate Cancer. Translational Cancer Research. doi 10.21037/tcr.2016.07.36Google Scholar

Wei, L, Wang, J, Lampert, E, Schlanger, S, DePriest, AD, Hu, Q, Gomez, EC, Murakam, M, Glenn, ST, Conroy, J, Morrison, C, Azabdaftari, G, Mohler, JL, Liu, S, Heemers, HV. Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators. Eur Urol. 2016 Jul 20. pii: S0302–2838 (16) 30406–7. doi: 10.1016/j.eururo.2016.07.008. [Epub ahead of print]Google Scholar

Mazzucchelli, Roberta, Gasparrini, Silvia, Galosi, Andrea B., Massari, Francesco, Raspollini, Maria Rosaria, Scarpelli, Marina, Lopez-Beltran, Antonio, Cheng, Liang, Montironi, Rodolfo Genitourinary Cancers: Molecular Determinants for Personalized Therapies. Urologia. 2016; 83 (3): 107–109.Google Scholar

Packer, JR, Maitland, NJ. The Molecular and Cellular Origin of Human Prostate Cancer. Biophys Acta. 2016 Jun; 1863(6 Pt A): 1238–60.Google Scholar

Fisher, KW, Zhang, S, Wang, M, Montironi, R, Wang, L, Baldrige, LA, Wang, JY, MacLennan, GT, Williamson, SR, Lopez-Beltran, A, Cheng, L. TMPRSS2-ERG Gene Fusion Is Rare Compared to PTEN Deletions in Stage T1a Prostate Cancer. Mol Carcinog. 2016 Aug 8. doi: 10.1002/mc.22535. [Epub ahead of print]CrossRefGoogle Scholar